UTHR

UNITED THERAPEUTICS CORP DEL

UTHR·91307C102·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

UTHR (UNITED THERAPEUTICS CORP DEL) is held by 293 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.9B), Avoro Capital Advisors LLC ($1.5B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 142 funds bought UTHR.

293
Holders
(22 Elite)
$19.4B
Total Value
48% (294)
Consensus
142 buying - 152 selling
13F: Insider & Congress: Updated regularly
UTHR

Smart Money Verdict

View all
Loading verdict
Held by 293 funds
22 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 16, 2026 · Activists Aug 14, 2026 · Congress Nov 21, 2025

InsiderRAROTHBLATT MARTINE ASell $152KOct 15, 2026
InsiderRAROTHBLATT MARTINE ASell $450KOct 15, 2026
InsiderRAROTHBLATT MARTINE ASell $147KOct 15, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
5.3M(-1.9%)$2.9B0.0%+47.27%
0
Increased
2.8M(+5.6%)$1.5B13.5%+117.63%
67
Decreased
1.9M(-4.2%)$1B0.0%-8.68%
0
Decreased
1.9M(-2.0%)$1B0.0%-8.68%
0
Increased
1.9M(+2.9%)$1B0.0%+221.79%
33
Decreased
1.7M(-4.4%)$925.8M1.3%+434.73%
0
Decreased
1.4M(-39.1%)$747.2M0.1%+59.19%
0
Decreased
996,598(-19.2%)$538.9M0.0%+135.29%
0
First report
831,129$450.1M0.2%-0.06%
0
Increased
624,068(+1.3%)$338.1M0.6%+106.48%
44
Decreased
546,002(-33.9%)$294.6M0.1%+77.86%
0
Increased
527,904(+3.0%)$286M0.1%+269.36%
32
Decreased
473,409(-10.4%)$256.5M0.0%+38.44%
0
Decreased
473,109(-22.2%)$256.3M0.0%+105.88%
0
Increased
467,209(+9.1%)$253.1M0.2%+5.02%
40
Increased
436,699(+6.7%)$236.6M0.0%+52.93%
33
Decreased
430,844(-1.3%)$233.4M0.0%+139.38%
0
Increased
409,074(+166.7%)$221.6M0.1%+2.61%
49
Increased
340,275(+22.4%)$184.4M0.0%+8.66%
37
Decreased
322,995(-1.3%)$175M0.2%+211.61%
0

Showing 1-20 of 305

1 / 16
UTHRUTHRUNITED THERAPEUTICS CORP DEL

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used